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Distribution of Cells Bearing Receptors for
a Colony-stimulating Factor (CSF-1) in Murine Tissues
Colony-stimulating factors (CSFs) are growth factors which
stimulate the formation of colonies of granulocytes and/or
macrophages (3, 14) by precursor cells in hemopoietic tissues
(reviewed in reference 13) . Four subclasses may be discerned
by their preferential effects on neutrophil, eosinophil, neutro-
phil-macrophage or macrophage colony formation (reviewed
in reference 17) . CSF-1 is a subclass discriminated from the
other subclasses by its detection in subclass-specific radioim-
muno- and radioreceptor assays (5, 16, 17) . L-cell CSF-1 is
identical to L-cell macrophage growth factor (19) and specifi-
cally stimulates the growth of mononuclear phagocytes and
their precursors (17, 18, 20) . It is a heavily glycosylated, sialic
acid-containing glycoprotein (molecular weight 40,000-86,000)
composed of two disulfide-bonded subunits (21, 22) . The spe-
cific binding ofradiolabeled CSF-1 to mononuclear phagocytes
and to cell lines derived from mononuclear phagocytic cells
has recently been demonstrated (8) . Several independent fmd-
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ABSTRACT
￿
CSF-1 is a subclass of the colony-stimulating factors that specifically stimulates the
growth of mononuclear phagocytes . We used the binding of 1251-CSF-1 at 0°C by single cell
suspensions from various murine tissues, in conjunction with radioautography, to determine
the frequency of binding cells, their identity, and the number of binding sites per binding cell .
For all tissues examined, saturation of binding sites was achieved within 2 h at 2-3 x 10-10M
1251-CSF-1 . The binding was irreversible and almost completely blocked by a 2 h preincubation
with 5 x 10-10M CSF-1 . 1251-CSF-1 binding was exhibited by 4.3% of bone marrow cells, 7.5%
of blood mononuclear cells, 2.4% of spleen cells, 20.5% of peritoneal cells, 11 .8% of pulmonary
alveolar cells and 0.4% of lymph node cells . Four morphologically distinguishable cell types
bound 125 1-CSF-1 : blast cells; mononuclear cells with a ratio of nuclear to cytoplasmic area (N/
C) >1 ; cells with indented nuclei ; and mononuclear cells with N/C <_1 . No CSF-1 binding cells
were detected among blood granulocytes or thymus cells . Bone marrow promyelocytes,
myelocytes, neutrophilic granulocytes, eosinophilic granulocytes, nucleated erythroid cells,
enucleated erythrocytes, and megakaryocytes also failed to bind . The frequency distribution of
grain counts per cell for blood mononuclear cells was homogenous . In contrast, those for bone
marrow, spleen, alveolar, and peritoneal cells were heterogeneous . The monocytes in blood or
bone marrow (small cells, with either indented nuclei or with N/C >1) were relatively uniformly
labeled, possessing
￿
3,000 binding sites per cell . Larger binding cells (e.g ., alveolar cells) may
possess higher numbers of receptors . It is concluded that CSF-1 binding is restricted to
mononuclear phagocytic cells and their precursors and that it can be used to identify both
mature and immature cells of this series .
ings indicate that the high affinity CSF-1 binding site described
in these studies is the receptor through which the biological
effects of CSF-1 are mediated (8, 21) .
In this study we examine the distribution, frequency, and
morphology of CSF-1 receptor-bearing cells in adult mouse
tissues. Binding conditions were chosen to ensure saturation of
the cell-surface receptors by 1251-CSF-1 and radioautography
was used to identify the binding cells and to determine the
number of CSF-1 receptors per cell. We report the existence of
a CSF-1 receptor, with common properties, on cells in a variety
oftissues and indicate its usefulness as a marker of both mature
and immature cells of the mononuclear phagocytic series .
MATERIALS AND METHODS
Preparation of 1251-CSF-1
L-cell CSF-I was purified as previously described (21, 22) . The purity was
checked by PAGE, with and without SDS under reducing and nonreducing
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©The Rockefeller University Press - 0021-9525/81/12/0848/06$1 .00conditions and by complexing with rabbit anti-CSF-1 antibody (21, 22) . The
purified CSF-1 was iodinated with carrier-free "I (Amersham Corp ., Arlington
Heights, Ill .) with full retention of biological activity (16, 21) . The biological
activity of the "'I-CSF-1 preparation was assessed either by radioimmunoassay
with 1311-CSF-I and double label counting (16, 21) or by immunoprecipitation
with excess rabbit anti-CSF-t antiserum(21)on the basis ofthe closecorrelation
between bioactivities and antibody-binding activities (l6, 21). Three different
preparations of 'ZSI-CSF-I were used in the experiments described here . "'I-
CSF-I preparations were stable when stored in HS-a-HEPES, alpha medium
(KC Biological Inc., Kansas City, Mo.) containing 25 mM HEPES (Gibco
Laboratories, Grand Island Biological Co ., Grand Island, N. Y .) in lieu of
bicarbonate, pH 7.3, with 10% (vol/vol) horse serum (Flow Laboratories, Inc.,
Rockville, Md .), at -20°C (half-life of biologically active CSF-I = 50 d) . They
were used no longer than 3 wk postiodination. Determinations of the specific
radioactivities, as described elsewhere (2l), were made at the time of each
experiment. The mean value was -106,000 cpm/ng of biologically active CSF-1
protein or 2,900 cpm/fmol, corresponding to an average of 1 atom of "'I per
biologically active CSF-I molecule . Molarity conversions are based on an M, for
the polypeptide moiety of CSF-1 of 28,000 (S . K. Das and E . R . Stanley,
manuscript in preparation) (2l) and the specific activity of purified CSF-I (--1 .6
x 106 U/mg protein) (22) .
Preparation of Cells
8- to 12-wk-old female C3H/Anfmice (Cumberland Farms, Nashville, Tenn .)
wereused exclusively. Unless otherwise stated, the animals were killed by cervical
dislocation and the cells suspended in HS-a-HEPES containing 5U/ml Heparin
(Upjohn Co., Agricultural Prods . MKT, Kalamazoo, Mich.) . When necessary,
cell suspensions were cleared of large and small cellular debris as described
elsewhere (15) . Viable cell counts were determined by Trypan blue exclusion and
cell suspensions with viabilities of >95% were used in binding experiments.
Unless otherwise stated, all operations were carried out at 4°C.
Bone marrow cells were obtained from femora, cleared of surrounding tissue
andopened by scalpel at both ends . The narrow plug was ejected into medium
by means ofa syringe connected to the femur via a piece of silicon tubing. The
cells were aspirated several times through the femur to ensure a single-cell
suspension. The cell yield was-7 x 106 nucleated cells/femur.
Spleen cells were obtained by forcing the tissue through a metal screen into
the collecting medium. The suspensionwas aspirated several times with a Pasteur
pipette to obtain a single-cell suspension . Approximately 10' cells were obtained
from each spleen .
Blood mononuclear cells and granulocytes were obtained by the method of
Boyum (2) . Mice were anaesthetized with ether and blood collected from the
axillary artery andmixed with 0.3MEDTA (50:1) to prevent coagulation. It was
diluted (1 :4) with 0.15 M NaCl and layered over a mixture of 6.3% Ficoll
(Pharmacia Fine Chemicals, Div . of Pharmacia Inc., Piscataway,N. J.) and 10%
Hypaque (Winthrop Laboratories, NewYork,N. Y .) . The tube was centrifuged
at 400 g for 30 min at 22°C. The interface layer of mononuclear cells was
collected and washed three times with phosphate buffered saline (PBS) and
resuspended in medium . The cell yield was 2-3x 106 cells per mouse . The pellet
of erythrocytes and granulocytes was resuspended in mouse serum containing 40
pM Dextran T500 (Pharmacia Fine Chemicals) . The cells were allowed to
sediment (1 g, 4°C, l h) and the supernatant granulocytes were removed, washed
twice with PBS (400 g, 4°C, 10 min), and resuspended in medium.
A single-cell suspension ofthymus cells was obtained by teasing apart thymus
tissue with a pair of #26 needles. The cells were washed twice with medium .
Thymus gland yielded 5-8x 10' cells .
Lymph node cells were collected from the inguinal, brachial, and mesenteric
lymph nodes by gently teasing them apart with #26 needles until a single-cell
suspension was obtained . The cells were washed twice ; 2-4 x 10' cells were
obtained permouse .
Resident peritoneal cells were obtained by flushing the peritoneal cavity with
10 ml ofcold medium as previously described (8) . Between 1-2 x 106 cells were
recovered per cavity.
Pulmonary alveolar cells were obtained by cannulation of the trachea and
lavage of the lungs three times with 0.5mM EDTA in PBS (11). Mice were killed
beforehand by an intraperitoneal injection of 0.1 ml of Nembutal (Agricultural
and Veterinary Products Division, Abbott Laboratories, North Chicago, Ill.).
Between 2-3x 10' cells were obtained from each mouse .
The macrophage cell line J-774.2 (6) has been shown to possess '251-CSF-I
binding sites (5, 8) . This line was used to determine optimal binding conditions
and as a reference cell population in most experiments. J-774.2 cells were
maintained in a-medium with 10% horse serum in spinner flasks . They were
harvested from cultures in log phase growth only (5-9x 105 cells/ml) and their
viability in all cases was >95%.
Cellular Binding of
1251-CSF-1
All operations were carried out at 0°C . Cells (usually 5 x 106 nucleated cells)
in HS-a-HEPES were added to precooled plastic 35-mm tissue culture dishes
(Lux Scientific Corp ., Newburg Park, Calif) and allowed to stand for 30 min . In
the case of blood mononuclear, alveolar, and peritoneal cells, <5 x 106 nucleated
cells per dish were used because of the limited cell yield per mouse . Stage 1 L-
cell CSF-1 (22) in HS-a-HEPES wasadded to control dishes (final concentration
5x 10- `° M) to saturate all CSF-1 binding sites before incubation with '2'I-CSF-
1 (2l). The remaining dishes received an equal volume of HS-a-HEPES . The
contents of each dish were thoroughly mixed and allowed to incubate for2 h .
"I-CSF-I was then added to all dishes with mixing (final volume 1 ml) and the
dishes incubated for a further 2 h . (For all cell populations studied, saturation
was observed at the "'I-CSF-1 concentration routinely used for binding [5 x
l0- '° M] .) The cells were then thoroughly resuspended and unbound ' 2'51-CSF-1
was removed by layering 0.8 ml of the suspension over 3 ml of filtered horse
serum in a 12 x 75-mm polypropylene tube (Falcon #2053) and centrifuging
(500 g, 15 min) . The supernate was removed by aspiration . The cell pellet was
resuspended in 0.2 ml medium and quantitatively transferred to anew tube, 0.3
ml of medium was added and the tube was centrifuging (500 g, 10 min)
immediately or after standing for 24 h . The supernate was discarded and the cell
pellet on ice was counted for 'z.I in an LKB 1280 Ultrogamma counter (LKB
Instruments, Inc ., Rockville, Md .). Cells were resuspended in fetal calf serum
and- I x 106 cells were smeared on precleaned glass slides. The cells were fixed
in cold methanol for 15 min, washed three times in H2O, air-dried, and then
processed for radioautography .
Radioautographs
Kodak NTB2 (Eastman Kodak Co., Rochester, N. Y.) was heated to 42°C
and a thin layer was applied to each slide by dipping. They were enclosed in
light-tight slideboxes, containing Drierite (W .A . Hammond Drierite Co ., Xenia,
Ohio) as desiccant, and exposed at 4°C for 4, 7, or 14 d . Slides were developed
at 22°C for 2 min in Kodak D-19 developer, dipped in 0.2 M acetic acid for 30
s and fixed for 3 min in Kodak Rapid Fixer. They were washed in running tap
water for 15 min and rinsed in distilled water . The cells were stained in 0.3% (wt/
vol) May-Griinwald in methanol for 15 min followed by 0.02% (wt/vol) Giemsa
in 3mM sodium phosphate bufferpH6.8 for 30 min . The emulsion was destained
in 20 mM acetic acid in ethanol, rinsed in buffer, and air-dried . Cells were
examined with a Zeiss Standard WL Microscope (Carl Zeiss, Inc., N. Y .). The
grain thresholdwas determined with the control cells that had been preincubated
with unlabeled CSF-1 . At least 1,000 sequential cells were examined in each
preparation .
RESULTS
The binding conditions were determined using the macrophage
cell line J-774.2 as the target cell population . Their ability to
bind 125I-CSF-I at 0°C has been previously demonstrated (8) .
Saturation of cellular binding was achieved, at concentrations
of 1251-CSF-1 >2 x 10- 'o M, within 2 h of incubation at 0°C
(Fig . 1 a) . There was a linear relationship between cpm bound
and cell concentration in the range 1 x 105 to 1 x 10 6 cells/ml
(Fig . 1 b). Binding was essentially irreversible as 1251 counts
remained cell bound when loaded cells were resuspended in
CSF-1-free medium for 24 h at 0°C (data not shown) . Binding
could be inhibited either by incubation in the presence of a 50-
fold excess of"cold" unlabeled CSF-1 or by a 2 h preincubation
with a saturating concentration of unlabeled CSF-1 (5 X 10-'o
M) . This latter procedure was routinely adopted to minimize
the use ofunlabeled CSF-1 . Complete inhibition of 125 1 binding
could not be achieved and the "net binding" refers to that
which could be inhibited . Net binding is the difference between
the two lines of Fig. 1 b.
Tissue cells were examined to see if the same binding con-
ditions applied. Bone marrow and spleen cells were incubated
with different concentrations of " 5I-CSF-1 . Because of the
lower incidence of binding cells in these suspensions, a higher
cell concentration of 5 X 106 cells/ml was necessary . A linear
relationship was found between cpm bound and cell concen-
tration in the range 1 X 106 to 1 X 10'/ml (data not shown) .
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FIGURE 1
￿
Binding of '251-CSF-1 to J-774.2 cells . (a) Kinetics of '25 1
binding by 0.4x 106 cells at 0°C in the presence of 3 x10"M 1251-
CSF-1 . Points represent means of duplicate values . (b) ' 25 1 binding
as a function of cell number . Cells were incubated for 2 h at 0°C
with 4.2 X 10-'o M '251-CSF-1 alone (C~-O) or after a 2 h
preincubation with 5 X 10- '°M unlabeled CSF-1 (~~) at 0°C.
Net binding is the difference between thetwo lines . Points represent
means of duplicate values .
Fig. 2 shows saturation binding curves for bone marrow and
spleen cells. Binding sites were saturated at concentrations
between 2 and 3 x 10-toM . Saturation was achieved within 2
h at 0°C . The binding was essentially irreversible for all the
tissues studied as further incubation of the loaded cells for 24
h at 0°C in CSF-1-free medium resulted in no loss of taeI
counts from the cells (not shown) .
Table I presents data on net binding for each of the tissues
studied . The percentage of labeled cells in each tissue was
determined from radioautographs which had been exposed for
4, 7, or 14 d . This percentage did not vary with exposure time,
although the number of grains per cell increased . Two cell
populations, thymic cells and blood granulocytes, showed no
CSF-1 binding. CSF-1 binding cells constituted a minor frac-
tion of the cells in the remaining tissues . The average number
of "'I-CSF-1 molecules bound per binding cell in these tissues
provides an estimate of the average number of receptors per
cell assuming that a receptor binds only one molecule of CSF-
1 . Values ranged from
￿
3,000 for blood mononuclear cells to
16,000 for pulmonary alveolar cells . A higher value of
19,000 was found with the macrophage cell line J-774.2 .
The labeled cells were morphologically classified into four
types : blast cells (Fig. 3 a) ; mononuclear cells with N/C > 1
(Fig . 3 b) ; cells with indented nuclei (including large and small
indentations) (Fig . 3 c) ; and mononuclear cells with N/C :51
(Fig . 3 d) . Blast cells were distinguished by finely divided
chromatin and sparse, often basophilic, cytoplasm. In the case
of the peritoneal and pulmonary alveolar cells, a large propor-
tion ofthe labeled cells that were classified as blast cellson the
basis of their sparse peripheral cytoplasm, could have been
multinucleated giant cells (macrophages), as their nuclear mor-
phology was obscured by the large number of overlying grains
(Fig . 3 e) . The greatest proportion oflabeled cells in each tissue
consisted of mononuclear cells with N/C >1 . Labeled mono-
nuclear cells with N/C :51 were found among lymph node,
peritoneal and alveolar cells . Labeled cells with indented nuclei
were found in all tissues except among alveolar cells.
Table II illustrates the extent to which a cell of a given
morphology possesses receptors for CSF-1 . In most cases both
labeled and unlabeled cells of a particular morphology were
found . However, in the case of blood mononuclear cells, all
monocytes with the distinctive indented or horseshoe-shaped
nuclei were found to be labeled. Granulocytic cells, nucleated
850
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FIGURE 2 Saturation binding curves for the binding of '251-CSF-1
by (a) bone marrow and (b)spleen cells . 4x 106 cells were incubated
for 2 h with 4 X 10-' °M '251-CSF-1 alone (O-O) or after a 2 h
preincubation with 5 X 10- ' ° M unlabeled CSF-1 (0--0) . Each
point is the mean of duplicate values .
TABLE I
Net Binding of 121 1-CSF-1 at Saturating Concentrations
* Net cpm bound was determined by subtracting cell-bound cpm of controls
(preincubated with "cold" CSF-1) from the cell bound cpm of those incu-
bations which received only ' 251-CSF-1 . Average values for the indicated
number of experiments . Each experiment consisted of duplicate incubations .
$The percentage of labeled cells in each experiment was determined from
duplicate smears exposed for 4, 7, or 14 d .
§Mean of experimental values. For each experiment the average number of
molecules bound per cell equaled the net cpm divided by
([cell no . x % labeled cells/100] x [cpm/fmol x 10'5/6.023 x 1023 1) .
The number of cpm/fmol of '251-CSF-1 was determined by radioimmunoas-
say with ' 3'I-CSF-1 ( 131 1-RIA) and immunoprecipitation with excess rabbit
anti-CSF-1 antiserum at the time of each experiment. Values ranged from
1,800 to 4,000 cpm/fmol .
erythroid cells, and mature erythrocytes were always found to
be unlabeled.
The number of grains per cell is a function of the number of
"'I-CSF-1 molecules bound . The distributions of grains per
cell among binding cells were heterogeneous in most popula-
tions examined, including bone marrow (Fig . 4a), alveolar
(Fig . 4 c) and spleen and peritoneal cells (not shown) . However,
as seen in Fig. 4b, blood mononuclear cells were relatively
homogeneous in terms of the number of grains per cell (10-45
grains/cell, 3,000 binding sites/cell) . They consisted ofmono-
nuclear cells with N/C > 1 (68%) and cells with accentuated
nuclear identations (32%) (Table II), both of which were char-
acterized as monocytes (see Discussion). Analysis of all three
tissues represented in Fig . 4 failed to reveal any other striking
correlation between cellular morphology and grain counts per

















Bone marrow 6 6,319 4.0 4.3 5,649 ± 187
Spleen 4 4,899 4.0 2.4 9,559 ± 1,123
Blood mononuclear 3 3,360 2.9 7.5 3,030 t 348
cells
Blood granulocytes 2 0 4.0 0 -
Peritoneal cells 2 6,059 1 .4 20.5 7,524
Pulmonary alveolar 2 1,091 0.2 11 .8 15,772
cells
Lymph nodes 2 661 4.0 0.4 8,398
Thymus 2 0 4.0 0 -
1774 .2 5 30,194 0.4 85 .0 18,794 t 2,179preparation were larger and bound more 1251-CSF-1 per cell
than the blood mononuclear binding cells .
DISCUSSION
A prior report demonstrated stable binding of 1251-CSF-1 to
mouse peritoneal exudate cells at 0°C (8) . At 37°C, ' 251-CSF-
1 is internalized and destroyed (21) . Binding at 0°C was
therefore used to determine the frequency of binding cells in
various tissues and to quantitate the number of unoccupied cell
surface CSF-1 binding sites per cell in these tissues . Despite
variations in the number of sites per cell between and often
within the tissue examined, the CSF-1 receptor exhibited sim-
ilar characteristics in all cell populations ; the saturation binding
conditions were found to be similar and binding was essentially
irreversible.
In all tissues examined, CSF-1 binding was restricted to four
cell types: blast cells ; mononuclear cells with N/C >1 ; cells
with indented nuclei; and mononuclear cells with N/C :51 .
CSF-1 binding blast cells were found in bone marrow, and in
a higher proportion among peritoneal and alveolar cells (in the
latter populations many "blast" cells were possibly multinucle-
ated giant cells) . Mononuclear cells (N/C >1) binding CSF-1
(cells with lymphocytelike morphology) were found in all
tissues . Binding cells with indented nuclei included promono-
cytes (7) and monocytes . Mononuclear cells (N/C <_1) (cells
with a macrophagelike morphology) that bound CSF-1 were
found among peritoneal, alveolar, and lymph node cells. In all
tissues studied, granulocytes (promyelocytes to mature neutro-
phils and eosinophils), nucleated and enucleated erythroid
cells, and megakaryocytes failed to bind CSF-1 . Furthermore,
the low frequency of binding cellsamong lymphocytelike cells
(N/C >1) in the blood mononuclear, thymic, and lymph node
cell populations makes it very unlikely that B or T lymphocytes
possess CSF-1 receptors . Thus the morphology of the binding
cells is consistent with the conclusion that they are either
mononuclear phagocytes or undifferentiated mononuclear
phagocytic precursor cells . Other kinds of evidence support
this conclusion . (a) Although many of the binding cells cannot
be identified (especially the blasts and mononuclear cells with
N/C >1), all of the identifiable mononuclear phagocytic cells
in most populations bind 1251-CSF-1 . All blood mononuclear
cells with an accentuated nuclear identation (classical blood
monocytes) bound 125I-CSF-1 . It was reported (8) that >95%
of adherent peritoneal cells (peritoneal macrophages) bound
1251-CSF-1 and that >98% of a population of adherent perito-
neal exudate cells (>99% of which displayed Fc-mediated
sheep erythrocyte phagocytosis) bound 1251-CSF-1 . (b) In this
study, CSF-1 binding cells were preferentially distributed
among tissues known to contain mononuclear phagocytic cells
(25). (c) The frequencies of binding cells (Table I) in the tissues
examined are in general agreement with the previously re-
ported frequencies of mononuclear phagocytic cells in these
tissues (bone marrow [27], blood monocytes from Ficoll-Hy-
paque sedimentation [4, 10], splenic monocytes or macrophages
[ 12], and peritoneal macrophages [23, 26]) . An exception to this
FIGURE 3 Radioautographs of ' 251-CSF-1 labeled cells at 4 d of
exposure . Bar, 20 pm . (a) Labeled blast cell (bone marrow) . (b)
Labeled mononuclear cell (N/C >1) (bonemarrow) . (c) Labeled cell
with indented nucleus (blood mononuclearcell) . (d) Labeled mono-
nuclear cells (N/C <_1) (pulmonary alveolar cells) . (e) Large labeled
"blast" cell (pulmonary alveolar cells) .
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851* Includes pulmonary alveolar and peritoneal cells which might be characterized as multinucleated giant cells .
$ Includes small, medium, and large lymphocytes and lymphocytelike cells .
§ Includes the series from promyelocyte to neutrophil and eosinophil .
Includes megakaryocytes, reticulum cells, and unidentified cells.
2.4% of the blood mononuclear cells possessed the accentuated nuclear indentation of typical monocytes and all of these cells were labeled .
TABLE II
Percentage of Labeled Cells among Different Nucleated Cell Types (Day 4 Radioautographs)
I




Distribution of grains per cell in 4-d radioautographs of
(a) bone marrow, (b) bloodmononuclear, and (c) pulmonary alveo-
lar cells . 200 labeled cells were examined in each case . Since the
alveolar cells were labeled with a '251-CSF-1 preparation of lower
specific radioactivity (2,400 cpm/fmol) than the preparation used
for the bone marrow and blood mononuclear cells (3,700 cpm/
fmol), the data in histogram c were normalized . The average grain
count per labeled bone marrow cell was divided by the average
number of receptors per labeled bone marrow cell (Table I) and the
resulting ratio multiplied by the average number of receptors per
labeled alveolar cell (Table I) to obtain a normalized average grain
count per labeled alveolar cell (-1 .5 times the actual average grain
count) . The distribution of grain counts per labeled alveolar cell was
then moved to the right by an amount equal to the difference
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observation was that the frequency of alveolar cells binding
CSF-1 was much lowerthan the reported frequencies ofalveo-
lar macrophages in such preparations (1, 10) . Indeed, many
alveolar cells, which by classical morphological criteria are
macrophages (N/C <_1, Fig . 3d), did not bind CSF-1 . (d) In all
tissuesexamined the frequencyofcellswhich respond to CSF-
1 by forming colonies ofmacrophages (18) was equal to or less
than the frequencyof binding cells .' Takentogether, theabove
evidence strongly suggests that the CSF-1 receptor is restricted
to undifferentiated and differentiated members of the mono-
nuclear phagocytic cell lineage . The reason why some macro-
phages, i.e ., the alveolar subset mentioned above, do not bind
CSF-1 is unclear .
Grain counts in radioautographs indicated that the number
ofCSF-1 binding sites per cell variedamong binding cells (Fig .
4) . With the exception of the relatively homogeneous distri-
bution for blood mononuclear cells, all tissues examined ex-
hibited heterogeneous distributions of grain counts per cell .
CSF-1 binding alveolar cells, of larger average size than bind-
ing cells from other tissues, also possessed a higher average
number of receptors than cells from other tissues (Table I) . In
agreement with this, thefrequency distribution of grain counts
associated with these cells was shifted towards higher grain
counts per cell compared with the distributions of CSF-1
binding cells in bone marrow and blood(Fig. 4). The observed
heterogeneity amongCSF-1 binding cells in tissues other than
blood could be explained in a variety of ways, e.g., microen-
vironmental variations in CSF-1 concentration, cell cycle state,
or state of differentiation .
An excellent correlation exists between the reported tissue
distribution of monocytes and the tissue distribution of cells
with grain counts of between 10 and 45 grains . Virtually all of
the mononuclear phagocytic cells in the peripheral blood
' In this regard, it would appear that the presence of the receptor is
necessary but is not sufficient for the CSF-1 proliferative response .
However, it has recently become clear that although not all CSF-1
receptor bearing cells have the capacity to proliferate, those that do









Bone marrow 3.9 24.9 1 .3
Spleen 0.7 88.2 4.7
Blood mononu- 0 95 .1 4.21
clear
Pulmonary alveolar 1 .4 33.6 1 .0
Total cells labeled
Bone marrow 0.1 3.1 1 .1
Spleen 0 1.6 0.8
Blood mononu- 0 5.1 2.41
clear
Pulmonary alveolar 1 .3 8.1 0
Peritoneal 0.4 17.0 2.7
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0 50 .6 17 .4 1.9
0 4.4 1 .6 0.4
0 0.7 0 0
63 .7 0.3 0 0
0 0 0 0
0 0 0 0
0 0 0 0
2.4 0 0 0
0.4 0 0 0
0.1 0 0 0mononuclear cell population are monocytes and 70-80% of
those in bone marrow are monocytes (7, 24) . CSF-1 binding
bloodmononuclear cells are tightly distributed (98% ofbinding
cells have between 10 and 45 grains per cell) . The major peak
(71%) of the more heterogeneously distributed binding cells in
bone marrow fall within this "monocyte" range . Thus it ap-
pears that the major binding cell class in blood and bone
marrow is the monocyte, of which approximately two-thirds
are mononuclear cells with N/C >1 and one-third cells with
deeply indented nuclei (Table II) and which are relatively
homogeneous in their expression ofthe CSF-1 receptor (3,000
receptors per cell).
By contrast, there are very few CSF-1 binding pulmonary
alveolar cellswith the morphology of the CSF-1 binding blood
mononuclear cells (cells with indented nuclei or small (5-10
fLM) cells with N/C >1, Table II) . It is significant that <5% of
the CSF-1 binding cells in this population have <45 grains per
cell ; i.e., the alveolar cell distribution (Fig . 4 c) lacks the "mon-
ocyte" peak .
The distribution, frequencies and morphologies of CSF-1
binding cells in murine tissues suggest that the CSF-1 receptor
is a specific marker of mononuclear phagocytic cells and their
precursors . The results demonstrate that binding by specific
growth factors may be used as a means of identifying both
mature and immature cellsof a differentiating cell lineage.
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